- In April 2025, Eko Health Inc., a leading provider of AI-powered cardiovascular devices, received FDA clearance for its CORE500 Digital Stethoscope with integrated heart failure detection features. The device is designed to assist clinicians in identifying early signs of heart failure during routine exams. Alongside this milestone, Eko raised USD 41 million in Series D funding to expand the reach of its Sensora platform, underscoring the company’s commitment to transforming cardiac care through intelligent software and remote monitoring solutions
- In April 2025, the PrediHealth Project, a Europe-based research initiative, launched an advanced AI-driven telemedicine platform that combines wearable devices with predictive analytics to manage chronic heart failure. The project demonstrated promising outcomes in reducing hospital readmissions and enhancing patient engagement, reinforcing the role of digital health software in long-term cardiovascular care strategies
- In March 2025, researchers introduced TRisk, a cutting-edge transformer-based AI model trained on large-scale UK health records to predict 36-month mortality in heart failure patients. TRisk achieved a concordance index of 0.845, significantly outperforming traditional models. The success of this tool showcases the growing integration of deep learning models into heart failure software applications, particularly in clinical decision support
